Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

arthrex australia pty ltd - 34878 - brush, cleaning, bur - a reusable brush is used to clean surgical instruments and/or endoscopes prior to a procedure.

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

takeda products ireland ltd - cholecalciferol; calcium carbonate - chewable tablet - 500/400 mg/iu - calcium, combinations with vitamin d and/or other drugs

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

60 degrees pharmaceuticals, llc - tafenoquine (unii: 262p8gs9l9) (tafenoquine - unii:262p8gs9l9) - arakoda is indicated for the prophylaxis of malaria in patients aged 18 years and older. arakoda is contraindicated in: the use of arakoda during pregnancy may cause hemolytic anemia in a fetus who is g6pd-deficient. treatment with arakoda during pregnancy is not recommended. if a pregnancy is detected during arakoda use, discontinue arakoda as soon as possible and switch to an alternative prophylactic drug for malaria during pregnancy [see warnings and precautions (5.2)] . available data with use of arakoda in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. in animal studies, there were increased abortions, with and without maternal toxicity when tafenoquine was given orally to pregnant rabbits at and above doses equivalent to about 0.4 times the clinical exposure based on body surface area comparisons. no fetotoxicity was observed at doses about 1.5 times the clinical exposure (based on body surface area compariso

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

rowex ltd - salbutamol - pressurised inhalation, suspension - 100 microgram(s) - selective beta-2-adrenoreceptor agonists; salbutamol

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - vandetanib (unii: yo460oq37k) (vandetanib - unii:yo460oq37k) - vandetanib 100 mg - caprelsa is indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. use caprelsa in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of caprelsa. do not use in patients with congenital long qt syndrome [see boxed warning ]. pregnancy category d [see warnings and precautions (5.14) ] risk summary based on its mechanism of action, caprelsa can cause fetal harm when administered to a pregnant woman. vandetanib is embryotoxic, fetotoxic, and teratogenic in rats, at exposures less than or equal to those expected at the recommended human dose of 300 mg/day. if caprelsa is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus. animal data when vandetanib was administered to female rats prior to mating and through the first week of pregnancy at a do

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - siltuximab - powder for solution for infusion - 400mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - siltuximab - powder for solution for infusion - 100mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

fortech products, inc. - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic health care personnel hand rub to help reduce bacteria that potentially can cause disease.

Iisrael - inglise - Ministry of Health

medison pharma ltd - cytarabine; daunorubicin as hcl - powder for concentrate for solution for infusion - cytarabine 100 mg/vial; daunorubicin as hcl 44 mg/vial - daunorubicin and cytarabine - vyxeos liposomal is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-aml) or aml with myelodysplasia-related changes (aml-mrc).

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - vandetanib -